ERBB2 and breast cancer: Breast cancer with triple-negative phenotype (TNBC) characterized by the absence of the estrogen receptor alpha (ERα), the progesterone receptor (PgR), and the human epidermal growth factor receptor-2 (HER2) expression represents the major phenotype associated with basal-like molecular subtype of breast cancer.